Lux Biosciences luxbio.com


Public list: Pharma Startups (4740) Eye Health (696)

Lux Biosciences is a clinical stage biotechnology company specializing in the development and commercialization of medications for serious ophthalmic diseases. With a product in NDA/MAA submission stage and several earlier-stage projects, Lux is building a high-growth, and sustainable ophthalmic company.

Lux Biosciences is a clinical stage biotechnology company specializing in the development and commercialization of medications for serious ophthalmic diseases. With a product in NDA/MAA submission stage and several earlier-stage projects, Lux is buil...Show all

Company (Alive / Active)

Phone: 201-946-0551

Fax:

Harborside Financial Center Plaza 10
14th Floor
Jersey City, 07302
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Lux Biosciences $128M Mar 6, 2012
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Lux Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
HBM Healthcare InvestmentsVenture CapitalZug, SwitzerlandSeries B
Prospect Venture PartnersVenture CapitalPalo Alto, California, United StatesDebt - IV, Debt - III, Series B, Series A
Novo HoldingsHolding CompanyHellerup, DenmarkDebt - IV, Debt - III, Series B, Series A, Seed VC
International Biotechnology TrustOtherLondon, England, United KingdomSeries B, Series A
HBM PartnersPrivate EquityZug, SwitzerlandDebt - IV, Debt - III, Series A, Seed VC
See all 8 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors Aug 19, 2011 Sep 17, 2013 Patent
Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors Oct 08, 2008 May 07, 2013 Patent
Ophthalmic compositions Aug 23, 2013 Application